WEKO3
アイテム
{"_buckets": {"deposit": "8f22e430-9cdf-4c8f-aae2-5f431c8b2158"}, "_deposit": {"created_by": 2, "id": "1988", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "1988"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00001988", "sets": ["9"]}, "author_link": ["9172", "9174", "9182", "9184", "9186", "9183", "9180", "9173", "9178", "9170", "9176", "9187", "9175", "9177", "9181", "9169", "9185", "9179", "9171"], "item_2_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2019-06-07", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageStart": "210", "bibliographicVolumeNumber": "20", "bibliographic_titles": [{"bibliographic_title": "BMC Nephrology"}]}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Background: High serum calcium levels should be avoided in patients on hemodialysis (HD) because they can induce cardiovascular diseases and worsen the patient\u0027s prognosis. In contrast, low serum calcium levels worsen the prognosis of patients with cerebral hemorrhage in the general population.\n So far, whether serum calcium levels in patients on HD are associated with cerebral hemorrhage remains unknown. This study aimed to reveal the association between serum calcium and cerebral hemorrhage in patients on HD, including in-hospital death, \nvolume of hematoma, and onset of cerebral hemorrhage. Methods: This cross-sectional case-control study included 99 patients on HD with cerebral hemorrhage at a single center between July 1, 2007 and December 31, 2017. Controls included 339 patients on HD at a single HD center between July 1, 2011 and June 30, 2012. Data on serum calcium level, patient demographics, and comorbid conditions were collected, and associations between cerebral hemorrhage and subsequent death were evaluated by multivariate logistic regression analysis. Further, the association of these backgrounds and hematoma volume was evaluated by multiple regression analysis. Results: Of the 99 patients, 32 (32%) died from cerebral hemorrhage. The corrected serum calcium level\n (odds ratio [OR], 2.49; 95% confidence interval [CI], 1.43-4.35; P \u003c 0.001) and antiplatelet drug use (OR, 3.95; 95% CI, 1.50-10.4; P = 0.005)had significant effects on the prognosis. Moreover, the corrected serum calcium (P = 0.003) and antiplatelet drug use (P = 0.01) were significantly correlated with hematoma volume. In the patients, the corrected serum calcium level (OR, 1.54; 95% CI, 1.07-2.22; P = 0.02) was associated with the onset of cerebral hemorrhage, as was pre-hemodialysis systolic blood pressure (per 10 mmHg) (OR, 1.40; 95% CI, 1.23-1.59; P \u003c 0.001). Conclusions: Although the precise mechanisms remain unknown, a high serum calcium level is associated with cerebral hemorrhage in patients on HD. Thus, we should pay attentions to a patient\u0027s calcium level.", "subitem_description_type": "Abstract"}]}, "item_2_description_63": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "BMC Nephrology, 20(1), art.no.210; 2019", "subitem_description_type": "Other"}]}, "item_2_publisher_33": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "BioMed Central Ltd."}]}, "item_2_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1186/s12882-019-1400-4", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_13": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "c The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated."}]}, "item_2_source_id_8": {"attribute_name": "EISSN", "attribute_value_mlt": [{"subitem_source_identifier": "14712369", "subitem_source_identifier_type": "ISSN"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kitamura, Mineaki"}], "nameIdentifiers": [{"nameIdentifier": "9169", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tateishi, Yohei"}], "nameIdentifiers": [{"nameIdentifier": "9170", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sato, Shuntaro"}], "nameIdentifiers": [{"nameIdentifier": "9171", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kitamura, Satoko"}], "nameIdentifiers": [{"nameIdentifier": "9172", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ota, Yuki"}], "nameIdentifiers": [{"nameIdentifier": "9173", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Muta, Kumiko"}], "nameIdentifiers": [{"nameIdentifier": "9174", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamashita, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "9175", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Uramatsu, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "9176", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Obata, Yoko"}], "nameIdentifiers": [{"nameIdentifier": "9177", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Mochizuki, Yasushi"}], "nameIdentifiers": [{"nameIdentifier": "9178", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nishikido, Masaharu"}], "nameIdentifiers": [{"nameIdentifier": "9179", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Izumo, Tsuyoshi"}], "nameIdentifiers": [{"nameIdentifier": "9180", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Harada, Takashi"}], "nameIdentifiers": [{"nameIdentifier": "9181", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Funakoshi, Satoshi"}], "nameIdentifiers": [{"nameIdentifier": "9182", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Matsuo, Takayuki"}], "nameIdentifiers": [{"nameIdentifier": "9183", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsujino, Akira"}], "nameIdentifiers": [{"nameIdentifier": "9184", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sakai, Hideki"}], "nameIdentifiers": [{"nameIdentifier": "9185", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Mukae, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "9186", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nishino, Tomoya"}], "nameIdentifiers": [{"nameIdentifier": "9187", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-18"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "BMCN20_210.pdf", "filesize": [{"value": "1.1 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1100000.0, "url": {"label": "BMCN20_210.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/1988/files/BMCN20_210.pdf"}, "version_id": "84a9eca6-83bb-47fc-ab2d-dc278048f4b1"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Cerebral hemorrhage", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Hemodialysis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Serum calcium", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis"}]}, "item_type_id": "2", "owner": "2", "path": ["9"], "permalink_uri": "http://hdl.handle.net/10069/39277", "pubdate": {"attribute_name": "公開日", "attribute_value": "2019-07-02"}, "publish_date": "2019-07-02", "publish_status": "0", "recid": "1988", "relation": {}, "relation_version_is_last": true, "title": ["Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis"], "weko_shared_id": -1}
Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis
http://hdl.handle.net/10069/39277
http://hdl.handle.net/10069/39277df7883ba-a655-4d85-8405-aa2d2261c28a
名前 / ファイル | ライセンス | アクション |
---|---|---|
BMCN20_210.pdf (1.1 MB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2019-07-02 | |||||
タイトル | ||||||
タイトル | Association between serum calcium levels and prognosis, hematoma volume, and onset of cerebral hemorrhage in patients undergoing hemodialysis | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Cerebral hemorrhage | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Hemodialysis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Serum calcium | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Kitamura, Mineaki
× Kitamura, Mineaki× Tateishi, Yohei× Sato, Shuntaro× Kitamura, Satoko× Ota, Yuki× Muta, Kumiko× Yamashita, Hiroshi× Uramatsu, Tadashi× Obata, Yoko× Mochizuki, Yasushi× Nishikido, Masaharu× Izumo, Tsuyoshi× Harada, Takashi× Funakoshi, Satoshi× Matsuo, Takayuki× Tsujino, Akira× Sakai, Hideki× Mukae, Hiroshi× Nishino, Tomoya |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Background: High serum calcium levels should be avoided in patients on hemodialysis (HD) because they can induce cardiovascular diseases and worsen the patient's prognosis. In contrast, low serum calcium levels worsen the prognosis of patients with cerebral hemorrhage in the general population. So far, whether serum calcium levels in patients on HD are associated with cerebral hemorrhage remains unknown. This study aimed to reveal the association between serum calcium and cerebral hemorrhage in patients on HD, including in-hospital death, volume of hematoma, and onset of cerebral hemorrhage. Methods: This cross-sectional case-control study included 99 patients on HD with cerebral hemorrhage at a single center between July 1, 2007 and December 31, 2017. Controls included 339 patients on HD at a single HD center between July 1, 2011 and June 30, 2012. Data on serum calcium level, patient demographics, and comorbid conditions were collected, and associations between cerebral hemorrhage and subsequent death were evaluated by multivariate logistic regression analysis. Further, the association of these backgrounds and hematoma volume was evaluated by multiple regression analysis. Results: Of the 99 patients, 32 (32%) died from cerebral hemorrhage. The corrected serum calcium level (odds ratio [OR], 2.49; 95% confidence interval [CI], 1.43-4.35; P < 0.001) and antiplatelet drug use (OR, 3.95; 95% CI, 1.50-10.4; P = 0.005)had significant effects on the prognosis. Moreover, the corrected serum calcium (P = 0.003) and antiplatelet drug use (P = 0.01) were significantly correlated with hematoma volume. In the patients, the corrected serum calcium level (OR, 1.54; 95% CI, 1.07-2.22; P = 0.02) was associated with the onset of cerebral hemorrhage, as was pre-hemodialysis systolic blood pressure (per 10 mmHg) (OR, 1.40; 95% CI, 1.23-1.59; P < 0.001). Conclusions: Although the precise mechanisms remain unknown, a high serum calcium level is associated with cerebral hemorrhage in patients on HD. Thus, we should pay attentions to a patient's calcium level. |
|||||
書誌情報 |
BMC Nephrology 巻 20, 号 1, p. 210, 発行日 2019-06-07 |
|||||
出版者 | ||||||
出版者 | BioMed Central Ltd. | |||||
EISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 14712369 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1186/s12882-019-1400-4 | |||||
権利 | ||||||
権利情報 | c The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | BMC Nephrology, 20(1), art.no.210; 2019 |